|
2024
|
Invention
|
Methods and compositions for treating mucositis.
Methods for treating a subject for mucositis ar... |
|
|
Invention
|
Modulators of ras gtpase.
RAS modulating compounds and methods of using the same are provided. T... |
|
2023
|
Invention
|
Uridine phosphorylase inhibitors to prevent or treat drug-induced pulmonary dysfunction.
The pre... |
|
2022
|
Invention
|
Uridine phosphorylase (upase) inhibitors for treatment of liver conditions.
Methods of treating ... |
|
|
Invention
|
Uridine phosphorylase inhibitors to prevent or treat drug-induced pulmonary dysfunction. The pres... |
|
2021
|
Invention
|
Heteroaryl modulators of ras gtpase. RAS modulating compounds and methods of using the same are p... |
|
|
Invention
|
Small molecule modulators of ras gtpase.
RAS modulating compounds and methods of using the same ... |
|
|
Invention
|
Uridine phosphorylase inhibitors to treat or prevent pulmonary disease. The present invention rel... |
|
|
Invention
|
Methods and compositions for treating mucositis. Methods for treating a subject for mucositis are... |
|
|
Invention
|
Methods and compositions for reducing radiation induced toxicity.
Methods for reducing radiation... |
|
|
Invention
|
Methods and compositions for maximizing the prevention and/or reduction of various maladies and d... |
|
2020
|
Invention
|
Uridine phosphorylase (upase) inhibitors for treatment of liver conditions. Methods of treating a... |
|
|
Invention
|
Non-mammalian ras transgenic animal model.
Non-mammalian, transgenic animals, e.g., flies, that ... |
|
|
Invention
|
Pyrazolopyrimidine modulators of ras gtpase. Pyrazolopyrimidine RAS modulating compounds and meth... |
|
2019
|
Invention
|
Methods and compositions for reducing radiation induced toxicity. Methods for reducing radiation ... |
|
|
Invention
|
Methods and compositions for reducing fluorouracil induced toxicity. Methods for reducing fluorou... |
|
|
Invention
|
Modulators of ras gtpase. RAS modulating compounds and methods of using the same are provided. Th... |
|
2018
|
Invention
|
Methotrexate adjuvants to reduce toxicity and methods for using the same. Methods are provided fo... |
|
2015
|
Invention
|
Doxorubicin adjuvants to reduce toxicity and methods for using the same. Methods are provided for... |
|
2014
|
Invention
|
Non-mammalian ras transgenic animal model. Non-mammalian, transgenic animals, e.g., flies, that i... |
|
2009
|
Invention
|
Methotrexate adjuvants to reduce toxicity and methods for using the same. Methods are prov... |
|
|
Invention
|
Toxicity-reducing nitrone adjuvants for doxorubicin and use of the same. Methods are provid... |
|
2008
|
Invention
|
Methods and compositions for use in homologous recombination.
Methods for homologously recombini... |
|
2007
|
Invention
|
Non-mammalian transgenic animal model for cellular proliferative diseases.
Non-mammalian, transg... |
|
2005
|
Invention
|
Reduced toxicity methotrexate formulations and methods for using the same.
Methods of using meth... |
|
|
Invention
|
Reduced toxicity methotrexate formulations and methods for using the same. Methods of using metho... |
|
2004
|
Invention
|
Methods and compositions for use in homologous recombination in plant cells. Methods for homologo... |
|
|
Invention
|
Reduced toxicity cisplatin formulations and methods for using the same. Methods of using cisplati... |
|
2003
|
Invention
|
Animal integration vector and methods for its use.
Novel P element containing vectors and method... |
|
|
Invention
|
Methods and compositions for use in homologous recombination. Methods for homologously recombinin... |
